miRNA-448介导STAT5上调在奥沙利铂诱导中枢敏感化和痛觉过敏中的作用及机制
基本信息
结项摘要
Oxaliplatin-induced allodynia is a common side effect limiting the treatment of cancer. Since the mechanism is unclear, there are no effective prevention and treatment measures. miRNAs microarray analysis revealed that oxaliplatin-induced downregulation of miRNA-448 may contribute to increase the STAT5 expression whereas STAT5 mRNA was unaltered. Intrathecal injection of STAT5 inhibitor significantly attenuated oxaliplatin-induced pain. However, the mechanism of miRNA-448 increased the expression of STAT5 and the role of STAT5 in the oxaliplatin-induced neuropathy remained unclear. In the present study, we found that intrathecal injection of STAT5 inhibitor suppressed the oxaliplatin-induced upregulation of Nav1.3. These results indicate that increased STAT5 may through the epigenetic regulation promoted the expression of Nav1.3 mediated oxaliplatin-induced central sensitization and allodynia. This project proposed by in vivo and in vitro experiments: 1) clarify the role of miRNA-448/STAT5 signaling pathway in central sensitization and allodynia induced by oxaliplatin; 2) clarify the epigenetic mechanism underlying STAT5 in the upregulation of Nav1.3. The project will provide new evidence that help to elucidate the mechanism of oxaliplatin-induced pain.
奥沙利铂诱导的痛觉过敏是制约其治疗肿瘤的重要原因，但机制不清，目前尚无有效防治手段。高通量预实验发现奥沙利铂诱导可能调控STAT5 mRNA的miRNA-448显著下调，脊髓背角STAT5蛋白上调，且STAT5 mRNA的水平不改变，然而miRNA-448如何介导STAT5上调，且STAT5如何参与痛觉过敏尚不清楚。我们还发现：鞘内注射STAT5抑制剂ON146040可显著抑制奥沙利铂诱导的脊髓背角Nav1.3表达上调。提示：上调的STAT5可能通过表观遗传学机制促进Nav1.3基因的转录，从而诱导痛觉过敏，相关内容目前并无文献报道。本项目拟在体内和体外实验中：1）明确miRNA-448促进STAT5表达在痛觉过敏中的作用及机制；2）探讨STAT5介导Nav1.3表达上调在痛觉过敏中的作用及机制。本项目研究将为防治化疗药诱导的痛觉过敏提供新的靶点。
项目摘要
奥沙利铂诱导的痛觉过敏是制约其治疗肿瘤的重要原因，但机制不清，目前尚无有效防治 手段。高通量预实验发现奥沙利铂诱导可能调控STAT5 mRNA的miRNA-448显著下调，脊髓背角S TAT5蛋白上调，且STAT5 mRNA的水平不改变，然而miRNA-448如何介导STAT5上调，且STAT5如 何参与痛觉过敏尚不清楚。我们还发现：鞘内注射STAT5抑制剂ON146040可显著抑制奥沙利铂 诱导的脊髓背角Nav1.3表达上调。经过本项目的研究发现：上调的STAT5通过表观遗传学机制促进Nav1.3基 因的转录，从而诱导痛觉过敏，相关内容目前并无文献报道。本项目初步明确了： 1）miRNA-448促进STAT5表达在痛觉过敏中的作用及机制；2）STAT5介导Nav1.3表达 上调在痛觉过敏中的作用及机制。本项目研究将为防治化疗药诱导的痛觉过敏提供新的靶点
项目成果
{{i.achievement_title}}
{{i.achievement_title}}
暂无此项成果
数据更新时间：2023-05-31
其他相关文献
Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction
Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction
Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation
Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation
DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素
DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素
Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x
Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x
基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像
基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像
黄真真的其他基金
相似国自然基金
MG通过表观遗传学介导Nav1.6上调在化疗药硼替佐米诱导中枢敏化和痛觉过敏的作用及机制
线粒体保护在瑞沙托维减轻奥沙利铂诱导的神经病理性疼痛中的作用
SRPK1诱导结肠癌奥沙利铂耐药的机制研究
星形胶质细胞Cx30在神经损伤诱导中枢敏化及痛觉过敏中的作用及机制